Optimal sample sizes for phase II clinical trials and pilot studies
- 3 November 2011
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 31 (11-12), 1031-1042
- https://doi.org/10.1002/sim.4357
Abstract
Methodology for sample size calculation for phase III clinical trials is well established and widely used. In contrast, for earlier phase clinical trials or pilot studies, although there is an acceptance that the methods used for phase III trials are not appropriate, there is little consensus over methods that should be used. This paper explores this problem from a Bayesian decision-theoretic perspective. The aim is to obtain sample sizes that would be appropriate for studies funded by a large funder such as a public sector body or major pharmaceutical company. The sample sizes obtained are optimal in that they minimise the average number of patients required per successfully identified effective therapy or equivalently maximise the number of effective therapies successfully identified over a long period. It is indicated that the number of patients included in a phase II clinical trial should be approximately 0.03 times that planned to be included in the phase III study. This is similar to that proposed by other researchers in this area, though rather smaller than actually used for many phase II trials. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Seamless phase II/III designsStatistical Methods in Medical Research, 2010
- Bayesian Optimal Design for Phase II Screening TrialsBiometrics, 2007
- Sample size of 12 per group rule of thumb for a pilot studyPharmaceutical Statistics, 2005
- Moving statistics beyond the individual clinical trial: applying decision science to optimize a clinical development planPharmaceutical Statistics, 2005
- Benefit–Risk Evaluation of Multi-Stage Adaptive DesignsSequential Analysis, 2004
- Exact computational analyses for adaptive designsPublished by Institute of Mathematical Statistics ,1995
- Sample sizes for phase II and phase III clinical trials: An integrated approachStatistics in Medicine, 1986
- Statistical considerations for pilot studiesInternational Journal of Radiation Oncology*Biology*Physics, 1980